Table 1 Characteristics of the obsessive–compulsive disorder group
Pat No | Age (y.) | Gen | Educ (y.) | Additional Medication (mg/d) | Y-BOCS (1–5/6–10) | HAM-D | BDI |
|---|---|---|---|---|---|---|---|
1 | 35 | F | 13 | Fluoxetine 60 | 18(5/13) | 8 | 28 |
2 | 35 | F | 14 | Fluoxetine 60 Carbamazepine 300 | 26(9/17) | 25 | 30 |
3 | 33 | F | 13 | Fluoxetine 20 | 19(12/7) | 6 | 7 |
4 | 35 | F | 13 | None | 15(0/15) | 14 | 13 |
5 | 35 | M | 14 | Fluvoxamine 150 | 26(15/11) | 16 | 19 |
6 | 47 | M | 13 | None | 22(12/10) | 14 | 14 |
7 | 31 | F | 13 | None | 23(13/10) | 12 | 4 |
8 | 24 | M | 15 | Paroxetine 20 | 24(15/9) | 15 | 6 |
9 | 56 | M | 19 | None | 32(17/15) | 14 | 4 |
10 | 29 | F | 13 | Fluoxetine 60 | 16(0/16) | 15 | 27 |
11 | 21 | M | 13 | Citalopram 20 | 16(11/5) | 32 | 33 |
12 | 32 | M | 12 | Venlafaxin 300 | 27(16/11) | 5 | 23 |
13 | 34 | M | 14 | None | 16(9/7) | 7 | 4 |
14 | 31 | M | 16 | Sertraline 50 | 23(9/14) | 21 | 22 |
15 | 35 | F | 16 | None | 35(17/18) | 29 | 31 |
16 | 20 | F | 13 | None | 20(7/13) | 5 | 7 |
Mean ± SD | 33.3 ± 8.8 | 14 ± 1.75 | 22.4 ± 5.86(10.4 ± 5.4/11.9 ± 3.8) | 14.9 ± 8.3 | 17 ± 10.8 |